Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

NCT02340169 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: Topicort® (desoximetasone) Topical Spray, 0.25%

Sponsor

Sun Pharmaceutical Industries, Inc.